EYLEA HD was launched in 2023 and entered the highly competitive environment described above
The FDA recently approved EYLEA HD for the treatment of RVO and for additional dosing regimens
no findingread · nothing bore on it
It held on this filing. No finding was written because nothing in it bore on the reason — the sentences it was read against are below.
the evidence · every sentence checkedtwo sentences · whole, uncut
the claims it rests on · in our words, not the filing’s
EYLEA HD was launched in 2023 and entered the highly competitive environment described above